arrow
返回

Oncogene addiction

delete2008-05-01
delete856
delete
OA
AI
I
I. Bernard Weinstein *
A
Andrew K. Joe
DOI:10.1158/0008-5472.CAN-07-3293delete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
Cancer cells contain multiple genetic and epigenetic abnormalities. Despite this complexity, their growth and survival can often be impaired by the inactivation of a single oncogene. This phenomenon, called oncogene addiction, provides a rationale for molecular targeted therapy. The efficacy of this strategy requires novel methods, including integrative genomics and systems biology, to identify the state of oncogene addiction (i.e., the Achilles heel) in specific cancers. Combination therapy may also be required to prevent the escape of cancers from a given state of oncogene addiction.
Keyword:
MULTISTAGE CARCINOGENESIS
CELL CIRCUITRY
EGF RECEPTOR
BCR-ABL
CANCER
RESISTANCE
MUTATION
DISORDERS
BREAST
MYC

期刊

Cancer Research 封面图
Cancer Research
IF:
16.6
论文数:
10.9W
被引数:
11.9W

机构

C
Columbia University
学者数:
7.1W
论文数: 6.4W
被引数: 263
引用论文

引用论文

Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch
err2006-10-31
err142
errOAAI
errGiuriato, Sylvie; Ryeom, Sandra; Fan, Alice C.; Bachireddy, Pavan; Lynch, Ryan C.; Rioth, Matthew J.; van Riggelen, Jan; Kopelman, Andrew M.; Passegue, Emmanuelle; Tang, Flora; Folkman, Judah; Felsher, Dean W.
err分享
err收藏
PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors
err2007-01-25
err130
PREAI
errMellinghoff, Ingo K.; Cloughesy, Tim F.; Mischel, Paul S.
err分享
err收藏
Aerosol α1 -antitrypsin treatment for cystic fibrosis
err1991-02-01
err0
PREAI
errN.G. McElvaney; R.C. Hubbard; P. Birrer; R.G. Crystal; M.S. Chernick; M.M. Frank; D.B. Caplan
err分享
err收藏
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
err2005-02-24
err3.8K
errOAAI
errKobayashi, S; Boggon, TJ; Dayaram, T; Janne, PA; Kocher, O; Meyerson, M; Johnson, BE; Eck, MJ; Tenen, DG; Halmos, B
err分享
err收藏
err分享
err收藏
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinibEGF受体的不可逆抑制剂可能会避免对吉非替尼的获得性耐药
err2005-05-16
err931
errOAAI
errKwak, EL; Sordella, R; Bell, DW; Godin-Heymann, N; Okimoto, RA; Brannigan, BW; Harris, PL; Driscoll, DR; Fidias, P; Lynch, TJ; Rabindran, SK; McGinnis, JP; Wissner, A; Sharma, SV; Isselbacher, KJ; Settleman, J; Haber, DA
err分享
err收藏
学者 查看更多内容